CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 48 filers reported holding CIDARA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $196,000 | -18.0% | 87,419 | -26.2% | 0.00% | 0.0% |
Q2 2021 | $239,000 | -52.0% | 118,482 | -36.7% | 0.00% | -66.7% |
Q1 2021 | $498,000 | +164.9% | 187,170 | +99.2% | 0.00% | +200.0% |
Q4 2020 | $188,000 | -5.1% | 93,960 | +35.2% | 0.00% | -66.7% |
Q3 2020 | $198,000 | -39.8% | 69,476 | -22.1% | 0.00% | -40.0% |
Q2 2020 | $329,000 | +1118.5% | 89,235 | +731.8% | 0.01% | +400.0% |
Q1 2020 | $27,000 | -83.8% | 10,728 | -47.9% | 0.00% | -66.7% |
Q3 2017 | $167,000 | – | 20,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
Prosight Management, LP | 245,764 | $578,000 | 0.30% |